EANS-Adhoc: LifeWatch completes major agreement for Home Sleep Testing with Sleep Management Solutions

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

29.05.2012

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE), the leading wireless cardiac monitoring service and
home sleep test provider in the U.S., announced today it has signed a
major contract with Sleep Management Solutions (SMS) for LifeWatch
home sleep testing. SMS, a subsidiary of CareCentrix Inc., provides
diagnostic and therapeutic management services of sleep medicine to
healthcare payers and employers in the United States. SMS's mission
is to address the increasing demands in the management of Sleep
Disordered Breathing (SDB), a market which is growing at an annual
rate of 20%. The new agreement with SMS is effective May 1, 2012.

SMS provides Sleep Benefits Management services to payer clients
throughout the United States. This new agreement is expected to
significantly increase enrollments for LifeWatch home sleep testing
services, and we have scaled up our operational platform in
anticipation of the increase in demand for this monitoring area.

"We are proud that Sleep Management Solutions has chosen our quality
Home Sleep Test service after a long and involved due diligence
process," stated Dr. Yacov Geva, Chairman and CEO of LifeWatch AG.
"As a provider of home sleep test technologies and services to SMS,
we will further increase our marketing footprint and solidify our
position in this accelerating area of healthcare."

end of ad-hoc-announcement ==========================================
====================================== About LifeWatch AG: LifeWatch
AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology
and solution company, specializing in advanced telehealth systems and
wireless remote patient monitoring services. LifeWatch services cater
to individuals, ranging from high-risk and chronically ill patients,
to consumers of health and wellness products. LifeWatch has
subsidiaries in the United States, the Netherlands, Japan, the United
Kingdom, Switzerland and Israel. LifeWatch AG is the parent company
of LifeWatch Serv-ices Inc., a leading US-based cardiac monitoring
service provider, and manufacturer of telecardiol-ogy products.
LifeWatch is also introducing a new program for Home Sleep Testing of
Obstructive Sleep Apnea (OSA) patients under the brand name
NiteWatch. For additional information, please visit
www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,”
“intend,” “expect” and similar expres-sions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
state-ments are based only on data available to LifeWatch AG at the
time of the issue of this press release. Life-Watch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Further inquiry note:
Sensus Investor and Public Relations GmbH, Zurich
Tel +41 43 366 55 11
Fax +41 43 366 55 12
Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English